AML or acute lymphoblastic leukemia (ALL) with KMT2A gene rearrangement (r), AML with NPM1 mutation (NPM1mut) and few other subtypes are dependent on downstream MEIS/HOXA activation for leukemogenesis and are amenable to menin inhibition [4]. The gene discussed is NPM1; the disease is acute myeloid leukemia.